NuCana (NCNA) Cash from Investing Activities (2017 - 2025)
NuCana's (NCNA) quarterly Cash from Investing Activities came in at $178242.3 in Q4 2025, up 531.24% year-on-year from $28237.0 in Q4 2024, and up 106.4% quarter-over-quarter from $86359.2 in Q3 2025.
NuCana (NCNA) Cash from Investing Activities (2017 - 2025) Analysis & Trends
NuCana has disclosed Cash from Investing Activities across 9 years of filings, most recently posting $178242.3 for Q4 2025.
- Cash from Investing Activities for Q4 2025 came in at $178242.3, up 531.24% year-over-year; the trailing twelve-month figure through Dec 2025 was $316225.9 (up 212.72% YoY), and the FY2025 annual result was $209643.1, up 107.6% from the prior year.
- Cash from Investing Activities came in at $178242.3 for Q4 2025 at NuCana, up from $86359.2 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $3.4 million in Q3 2023 to a low of -$3.9 million in Q3 2021.
- The 5-year median for Cash from Investing Activities is $28509.2 (2024), against an average of -$42517.4.
- Across the five-year window, Cash from Investing Activities tumbled 406.97% in 2021 and soared 3249.53% in 2023, its largest moves.
- NuCana's Cash from Investing Activities stood at -$624128.9 in 2021, then soared by 130.07% to $187668.5 in 2022, then plunged by 64.95% to $65781.0 in 2023, then sank by 57.07% to $28237.0 in 2024, then soared by 531.24% to $178242.3 in 2025.
- The last three Cash from Investing Activities figures came in at $178242.3 (Q4 2025), $86359.2 (Q3 2025), and $28237.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 579,519.10 |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 178,242.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 178,242.27 |
| Dec 31, 2025 | 178,242.27 |
| Sep 30, 2025 | 86,359.18 |
| Sep 30, 2025 | 86,359.18 |
| Dec 31, 2024 | 28,237.04 |
| Dec 31, 2024 | 28,237.04 |
| Sep 30, 2024 | 23,387.40 |
| Sep 30, 2024 | 23,387.40 |
| Jun 30, 2024 | -5,048.88 |
| Jun 30, 2024 | -5,048.88 |
| Mar 31, 2024 | 54,546.28 |
| Mar 31, 2024 | 54,546.28 |
| Dec 31, 2023 | 65,781.05 |
| Dec 31, 2023 | 65,781.05 |
| Sep 30, 2023 | 3.36 Mn |
| Sep 30, 2023 | 3.36 Mn |
| Jun 30, 2023 | 28,781.35 |
| Jun 30, 2023 | 28,781.35 |
| Mar 31, 2023 | 198,128.05 |
| Mar 31, 2023 | 198,128.05 |